GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » Cyclically Adjusted Revenue per Share

Universal Biosensors (ASX:UBI) Cyclically Adjusted Revenue per Share : A$0.12 (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Universal Biosensors's adjusted revenue per share for the three months ended in Sep. 2024 was A$0.006. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is A$0.12 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -7.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Universal Biosensors was 7.70% per year. The lowest was -7.70% per year. And the median was -6.70% per year.

As of today (2025-01-18), Universal Biosensors's current stock price is A$0.095. Universal Biosensors's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was A$0.12. Universal Biosensors's Cyclically Adjusted PS Ratio of today is 0.79.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Universal Biosensors was 7.62. The lowest was 0.80. And the median was 2.08.


Universal Biosensors Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Universal Biosensors's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Biosensors Cyclically Adjusted Revenue per Share Chart

Universal Biosensors Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.14 0.13 0.12 0.11

Universal Biosensors Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.11 0.12 0.12 0.12

Competitive Comparison of Universal Biosensors's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Universal Biosensors's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Biosensors's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Biosensors's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Universal Biosensors's Cyclically Adjusted PS Ratio falls into.



Universal Biosensors Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Universal Biosensors's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.006/129.1850*129.1850
=0.006

Current CPI (Sep. 2024) = 129.1850.

Universal Biosensors Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.026 99.002 0.034
201503 0.022 99.187 0.029
201506 0.035 99.838 0.045
201509 0.034 100.302 0.044
201512 0.019 100.673 0.024
201603 0.031 100.488 0.040
201606 0.030 100.859 0.038
201609 0.019 101.602 0.024
201612 0.028 102.159 0.035
201703 0.045 102.624 0.057
201706 0.036 102.809 0.045
201709 0.036 103.460 0.045
201712 0.026 104.110 0.032
201803 0.043 104.574 0.053
201806 0.033 104.945 0.041
201809 0.266 105.410 0.326
201812 0.049 105.967 0.060
201903 0.011 105.967 0.013
201906 0.012 106.617 0.015
201909 0.008 107.174 0.010
201912 0.008 107.917 0.010
202003 0.003 108.289 0.004
202006 0.003 106.246 0.004
202009 0.002 107.917 0.002
202012 0.010 108.846 0.012
202103 0.009 109.496 0.011
202106 0.010 110.332 0.012
202109 0.007 111.168 0.008
202112 0.007 112.654 0.008
202203 0.010 115.069 0.011
202206 0.007 117.112 0.008
202209 0.003 119.248 0.003
202212 0.004 121.477 0.004
202303 0.006 123.148 0.006
202306 0.006 124.170 0.006
202309 0.009 125.656 0.009
202312 0.010 126.399 0.010
202403 0.007 127.606 0.007
202406 0.006 128.906 0.006
202409 0.006 129.185 0.006

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Universal Biosensors  (ASX:UBI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Universal Biosensors's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.095/0.12
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Universal Biosensors was 7.62. The lowest was 0.80. And the median was 2.08.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Universal Biosensors Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Biosensors Business Description

Traded in Other Exchanges
N/A
Address
1 Corporate Avenue, Rowville, VIC, AUS, 3178
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.

Universal Biosensors Headlines

No Headlines